Dr. Colin Franz Receives Development Grant for Research on Activity-Based Treatments to Accelerate Peripheral Axon Regeneration

    5/13/2022
Colin Franz, MD, PhD, was selected to receive a development grant from the ANF in 2021 for his research project “Activity-Based Treatments to Accelerate Peripheral Axon Regeneration.” Franz’s research will set the stage for a follow-up clinical trial to bring the most promising therapy to patients.

Dr. Elie Naddaf Receives Development Grant for Research on the Role of Mitochondria in Inclusion Body Myositis

    4/28/2022
Dr. Naddaf is a neurologist, specializing in NM disease, at the Mayo Clinic in Rochester, Minnesota. Dr. Naddaf’s research objective is to describe the precise nature of mitochondrial dysfunction in IBM. His long-term goal is to identify better diagnostic biomarkers for IBM and novel evidence-based, targetable pathways for clinical trials.

Dr. Yohei Harada Receives Development Grant for Research on Neuromuscular Ultrasound and Electric Impedance Myography in CMT

    4/13/2022
Yohei Harada, MD, was selected to receive a development grant from the ANF in 2021 for his research project “Neuromuscular Ultrasound and Electric Impedance Myography in CMT type 1A:A Prospective Longitudinal Study.”

Dr. Alexander Chamessian Receives ANF Development Grant

    9/8/2020
Alexander Chamessian, MD, PhD, has been selected as a recipient of an American Neuromuscular Foundation Development Grant. Dr. Chamessian’s project is called “Determining the Pathogenicity of Autoantibodies in Idiopathic Small Fiber Neuropathy.” Small fiber neuropathy (SFN) is a group of disorders that involves preferential damage to and dysfunction of small diameter sensory and autonomic nerve fibers.
 

Dr. R. James Cotton Receives Clinical Research Fellowship

    8/19/2020
R. James Cotton, MD, PhD, has been selected as the recipient of the American Neuromuscular Foundation’s (ANF) Clinical Research Fellowship to provide insights and answers about the safety and effectiveness of the neurological application of neurotoxins.
 

Dr. Carlo Rinaldi Receives Co-Funded ANF/MDA Grant for Research on Spinal and Bulbar Muscular Atrophy

    9/19/2018
Carlo Rinaldi, MD, PhD, has been selected as the recipient of a development grant co-funded by the ANF and the Muscular Dystrophy Association (MDA). Dr. Rinaldi, who works as an Associate Professor in the Department of Physiology, Anatomy and Genetics in the Division of Medical Sciences at the University of Oxford in the United Kingdom, will be using this funding to increase understanding of the pathophysiology of spinal and bulbar muscular atrophy (SBMA). 

Dr. Suma Babu Receives ANF Development Grant for Research on Spinal Cord Neuroinflammation in ALS Patients

    9/14/2018
Suma Babu, MBBS, MPH, has been selected as the recipient of an ANF development grant. Dr. Babu, who is an Instructor in Neurology at Harvard Medical School and faculty in the Neuromuscular division of Massachusetts General Hospital, will be using this funding to study the role of inflammation in the spinal cords of people living with amyotrophic lateral sclerosis (ALS). ALS is a neurodegenerative disorder affecting more than 15,000 Americans annually. 

Update on Dr. Lisa Williams’ Clinical Research in the Neurological Application of Neurotoxins

    1/8/2018
In 2016, the foundation was pleased to select Lisa M. Williams, MD, as the recipient of the Clinical Research Fellowship Award in Neurological Application of Neurotoxins. Dr. Williams used this funding to continue her focus on dysphagia in neuromuscular diseases while completing a second fellowship at the University of California, Davis Medical Center (UCDMC). Her research efforts as part of this fellowship award began on August 1, 2016, and continued through July 31, 2017.